AT1 blockers: are there alternative pathways reducing cardiovascular risk? Introduction.
van Zwieten
Peter A
PA
Departments of Pharmacotherapy, Cardiology and Cardiothoracal Surgery, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Julius
Stevo
S
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D044140:Receptor, Angiotensin, Type 1; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000528:radiation effects
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1